Featured Clinical Trials To Be Presented At Transcatheter Cardiovascular Therapeutics 2009 In San Francisco

Main Category: Cardiovascular / Cardiology
Also Included In: Clinical Trials / Drug Trials;  Medical Devices / Diagnostics;  Statins
Article Date: 21 Aug 2009 - 3:00 PDT

email to a friend   printer friendly   view / write opinions

Special presentations will be made Sept. 24, 2-6 p.m.

WHAT: A series of Featured Clinical Trials will be presented at Transcatheter Cardiovascular Therapeutics (TCT), in addition to late-breaking clinical trials. These featured clinical trials represent groundbreaking research and will yield data and insight that will further the field of interventional cardiology.

WHEN: The TCT Featured Clinical Trials will be presented on September 24, 2009 from 2:00 - 6:00 pm.

Session I. Drug-Eluting Stents

• ZEST: Final Angiographic and IVUS Results From a Large-Scale Randomized Trial of Zotarolimus-Eluting, Sirolimus-Eluting and Paclitaxel-Eluting Stents Cheol Whan Lee, MD
  
  
• CEREA-DES: A Prospective Randomized Trial of Corticosteroids in Patients Undergoing Stent Implantation Flavio L Ribichini, MD
  
  
• STATINS PRE-PCI: A Prospective Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina Josef Veselka, MD, PhD
  
  
• NEVO RES-ELUTION I QOL: Formal Quality-of-Life Assessment from a Prospective Randomized Trial of a Novel Sirolimus-Eluting Stent and a Paclitaxel-Eluting Stent John A. Spertus, MD
  
  
• CILOTAX: A Prospective, Randomized, Controlled Trial of a Stent Eluting Cilostazol and Paclitaxel Cheol Whan Lee, MD
  
  
• BIOFREEDOM: A Prospective Randomized Trial of a Polymer-Free Biolimus A9-Eluting Stent Eberhard Grube, MD

Session II. ACS Therapies and Novel Imaging Approaches

• MISTRAL: A Prospective Randomized Trial of Ambulance-Initiated vs. Cath Lab-Initiated Intravenous Abciximab in Patients with STEMI Patrick Ohlmann, MD, PhD
  
  
• COCKTAIL: A Prospective Randomized Trial of Intracoronary Abciximab Infusion in Patients with Thrombotic Lesions Assessed by OCT Francesco Prati, MD
  
  
• NO REFLOW: A Prospective Randomized Trial of Intracoronary vs. Guide Catheter Infusion of Nitrates vs. Calcium Channel Blockers in Patients with No Reflow After Primary PCI in STEMI Junbo Ge, MD
  
  
• OCTAMI: A Prospective Randomized Trial of Zotarolimus-Eluting and Bare-Metal Stents in STEMI Assessed by OCT Giulio Guagliumi, MD

Session III. End-Stage, Structural Heart and Endovascular Intervention

• The Canadian Transcatheter Aortic Valve Implantation Program: Acute and Late Follow-up from a Multicenter Consecutive Series of Patients with Inoperable or High-Surgical Risk Aortic Stenosis Josep Rodes-Cabau, MD
  
  
• CROSS-CLI: A Prospective Multicenter Registry of Ultrasound-Facilitated Recanalization of Peripheral Chronic Total Occlusions David E. Allie, MD
  
  
• ARMOUR: A Prospective, Nonrandomized Study of the Mo.Ma Proximal Cerebral Protection Device in High Surgical Risk Subjects Undergoing Carotid Artery Stenting Gary M. Ansel, MD
  
  
• PROVASA: A Prospective, Randomized, Placebo-Controlled Trial of Intra-Arterial Progenitor Cell Transplantation of Bone Marrow Mononuclear Cells in Patients with Peripheral Arterial Occlusive Disease Dirk H. Walter, MD
  
  
• ACT34-CMI: One-Year Results from a Prospective, Randomized, Placebo-Controlled Phase II Trial of CD34+ Cells in Patients with Refractory Angina Douglas W. Losordo, MD

WHERE: The Moscone Center San Francisco, CA

Source:
Judy Romero
Cardiovascular Research Foundation